If you’re thinking engaging Bosely Medical for any reason, be aware of their not-so-sterling practices. As The Wall Street Journal reports this week:
“U.S. regulators accused a leading hair-transplant chain of colluding with a rival to share confidential information about prices and products. In response, Bosley Inc., a unit of Japan’s Aderans Co., agreed with the Federal Trade Commission not to divulge such information to competitors in the future. It didn’t admit or deny the FTC’s allegations.”
The full story here:
online.wsj.com/article/SB1000142 … lenews_wsj
And of course this shocker from last summer: